Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Antiviral therapy for chronic hepatitis B.

Jafri SM, Lok AS.

Clin Liver Dis. 2010 Aug;14(3):425-38. doi: 10.1016/j.cld.2010.05.005. Review.

PMID:
20638023
2.

Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.

Chien RN, Liaw YF.

Best Pract Res Clin Gastroenterol. 2008;22(6):1081-92. doi: 10.1016/j.bpg.2008.11.003. Review.

PMID:
19187868
3.
4.

A proposed, evidence-based approach to the treatment of chronic Hepatitis B.

Han SH, Durazo FA, Saab S, Tong MJ.

J Clin Gastroenterol. 2011 Mar;45(3):259-66. doi: 10.1097/MCG.0b013e3181f312f5. Review.

PMID:
20856136
6.

Hepatitis B virus infection--natural history and clinical consequences.

Ganem D, Prince AM.

N Engl J Med. 2004 Mar 11;350(11):1118-29. Review. No abstract available. Erratum in: N Engl J Med. 2004 Sep 16;351(12):351.

PMID:
15014185
7.

[Chronic hepatitis B].

Thimme R, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2008 Jan;133(4):135-8. doi: 10.1055/s-2008-1017488. Review. German. No abstract available.

PMID:
18197589
8.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
9.

Chronic hepatitis B: who to treat and which choice of treatment?

Di Marco V, Craxì A.

Expert Rev Anti Infect Ther. 2009 Apr;7(3):281-91. doi: 10.1586/eri.09.4. Review.

PMID:
19344242
10.

[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].

Xu Y, Wang JB, Xu J, Jiao J, Zhang YG, Ji SW, Zhao P, Guo HH, Li Y, Zhou CY.

Zhonghua Gan Zang Bing Za Zhi. 2010 Feb;18(2):109-12. doi: 10.3760/cma.j.issn.1007-3418.2010.02.008. Chinese.

PMID:
20196949
11.

A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.

Mazur W, Król F, Cianciara J, Nazzal K, Gładysz A, Juszczyk J, Bolewska B, Adamek J, Czajka B, Swietek K, Kryczka W, Gonciarz Z.

Med Sci Monit. 2002 Apr;8(4):CR257-62.

PMID:
11951067
12.

Management of viral hepatitis B.

Pramoolsinsup C.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.

PMID:
12000599
13.

Therapeutic strategies for chronic hepatitis B virus infection in 2008.

Khokhar A, Afdhal NH.

Am J Med. 2008 Dec;121(12 Suppl):S33-44. doi: 10.1016/j.amjmed.2008.09.027.

PMID:
19185073
14.

Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL.

Gastroenterology. 2010 Aug;139(2):491-8. doi: 10.1053/j.gastro.2010.03.059. Epub 2010 Apr 8.

PMID:
20381492
15.
16.

Emerging therapies of hepatitis B and C.

Chen RY, Desmond PV, Locarnini SA.

J Gastroenterol Hepatol. 2002 Dec;17 Suppl:S471-81. Review. No abstract available.

PMID:
12534781
18.

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature.

Mommeja-Marin H, Mondou E, Blum MR, Rousseau F.

Hepatology. 2003 Jun;37(6):1309-19. Review.

PMID:
12774009
19.

Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.

Hui CK, Leung N, Shek WH, Zhang HY, Luk JM, Poon RT, Lo CM, Fan ST, Lau GK; Hong Kong Liver Fibrosis Study Group.

J Clin Gastroenterol. 2008 May-Jun;42(5):533-8. doi: 10.1097/MCG.0b013e31804bbdff.

PMID:
18344885
20.

Halting the natural history of hepatitis B viral infection: a paradigm shift.

Perrillo RP, Jacobson IM.

Semin Liver Dis. 2007 Aug;27 Suppl 1:3-8. Review.

PMID:
17701844

Supplemental Content

Support Center